| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.46▼ | 5.46▼ | 5.65▼ | 6.10▼ | N/A |
| MA10 | 5.72▼ | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | -100.000▼ | N/A | N/A | N/A | N/A |
| CCI | -132.178▼ | N/A | N/A | N/A | N/A |
|
Sunday, June 15, 2025 02:26 AM
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the 16 stocks Jim Cramer recently discussed. When a caller asked about the company during the lightning round, Cramer remarked: “You know what, ...
|
|
Monday, May 26, 2025 10:16 PM
Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported in Q4 CY2024, with sales up 15.6% year on year to $747.3 million. The company’s full-year revenue guidance of $3.15 billion at the ...
|
|
Sunday, May 18, 2025 05:31 AM
O n May 16, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced a $270 million acquisition of Inozyme Pharma, aiming to expand its rare disease research.The all-cash deal, backed by both ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 5.51 | 5.51 | 4.82 | 4.96 | 113,600 |
| 12/06/25 | 6.55 | 6.55 | 5.55 | 5.61 | 102,100 |
| 11/06/25 | 6.75 | 6.95 | 6.30 | 6.30 | 44,600 |
| 10/06/25 | 6.99 | 6.99 | 6.75 | 6.75 | 17,053 |
| 09/06/25 | 7.53 | 7.595 | 6.36 | 6.89 | 286,304 |
|
|
||||
|
|
||||
|
|